ATA92982A - Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin - Google Patents

Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin

Info

Publication number
ATA92982A
ATA92982A AT0092982A AT92982A ATA92982A AT A92982 A ATA92982 A AT A92982A AT 0092982 A AT0092982 A AT 0092982A AT 92982 A AT92982 A AT 92982A AT A92982 A ATA92982 A AT A92982A
Authority
AT
Austria
Prior art keywords
piperacillin
producing
dosing unit
parenteral dosing
pharmaceutical parenteral
Prior art date
Application number
AT0092982A
Other languages
English (en)
Other versions
AT395533B (de
Inventor
Bruce Edwin Haeger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA92982(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ATA92982A publication Critical patent/ATA92982A/de
Application granted granted Critical
Publication of AT395533B publication Critical patent/AT395533B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0092982A 1981-03-26 1982-03-09 Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin AT395533B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26

Publications (2)

Publication Number Publication Date
ATA92982A true ATA92982A (de) 1992-06-15
AT395533B AT395533B (de) 1993-01-25

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0092982A AT395533B (de) 1981-03-26 1982-03-09 Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin

Country Status (23)

Country Link
JP (1) JPS57159708A (de)
AT (1) AT395533B (de)
AU (1) AU549784B2 (de)
BE (1) BE892541A (de)
CA (1) CA1209477A (de)
CH (1) CH652306A5 (de)
DE (2) DE3208505A1 (de)
DK (1) DK157976C (de)
ES (1) ES8302455A1 (de)
FR (1) FR2502624B1 (de)
GB (1) GB2095551B (de)
GR (1) GR78386B (de)
HK (1) HK39189A (de)
HU (1) HU186489B (de)
IE (1) IE52936B1 (de)
IL (1) IL64924A (de)
IT (1) IT1147916B (de)
LU (1) LU84031A1 (de)
NL (1) NL192664C (de)
NZ (1) NZ199632A (de)
PL (1) PL130564B1 (de)
SE (1) SE453153B (de)
ZA (1) ZA82605B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
ATE411797T2 (de) 2003-10-23 2008-11-15 Otsuka Pharma Co Ltd Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
MY152789A (en) 2007-07-31 2014-11-28 Otsuka Pharma Co Ltd Methods for producing aripiprazole suspension and freeze-dried formulation
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
IE52936B1 (en) 1988-04-13
GB2095551A (en) 1982-10-06
NL8201251A (nl) 1982-10-18
CH652306A5 (de) 1985-11-15
PL130564B1 (en) 1984-08-31
NZ199632A (en) 1985-07-12
BE892541A (fr) 1982-09-20
IL64924A0 (en) 1982-04-30
FR2502624B1 (fr) 1985-10-25
IE820703L (en) 1982-09-26
NL192664B (nl) 1997-08-01
ES509234A0 (es) 1982-12-16
CA1209477A (en) 1986-08-12
IL64924A (en) 1985-07-31
DK157976C (da) 1990-08-27
SE453153B (sv) 1988-01-18
PL235509A1 (de) 1982-12-20
AU549784B2 (en) 1986-02-13
HU186489B (en) 1985-08-28
DK48382A (da) 1982-09-27
ZA82605B (en) 1982-12-29
JPH0219804B2 (de) 1990-05-07
SE8200591L (sv) 1982-09-27
LU84031A1 (de) 1982-07-08
ES8302455A1 (es) 1982-12-16
DE3208505C2 (de) 1991-11-28
GR78386B (de) 1984-09-26
DK157976B (da) 1990-03-12
FR2502624A1 (fr) 1982-10-01
IT8248034A0 (it) 1982-03-19
IT1147916B (it) 1986-11-26
DE3208505A1 (de) 1982-10-21
DE19375106I2 (de) 2006-02-16
JPS57159708A (en) 1982-10-01
HK39189A (en) 1989-05-19
NL192664C (nl) 1997-12-02
AU7986582A (en) 1982-09-30
AT395533B (de) 1993-01-25
GB2095551B (en) 1984-10-03

Similar Documents

Publication Publication Date Title
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT380476B (de) Verfahren zur herstellung von chinazolinderivaten
AT384022B (de) Verfahren zur herstellung von 1,2,4-triazol-3onen
AT371708B (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
ATE52892T1 (de) Verfahren zur herstellung eines gewuerzes.
DE3676049D1 (de) Verfahren zur herstellung von thermoplastischen massen.
AT381091B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT371744B (de) Verfahren zur herstellung von foerderschnecken
DE3674048D1 (de) Verfahren zur herstellung von imidaten.
ATA221181A (de) Verfahren zur herstellung von einer pharmazeutischen zusammensetzung
DE3580350D1 (de) Verfahren zur herstellung einer frukto-oligosaccharose.
ATA92982A (de) Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin
ATA238582A (de) Verfahren zur herstellung von neuen prolinderivaten
AT380477B (de) Verfahren zur herstellung von neuen spirothiazolidindion-derivaten
AT380005B (de) Verfahren zur herstellung von gipsprodukten
DE3785021D1 (de) Verfahren zur herstellung von neuraminidase.
AT377264B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT381318B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
DE3672289D1 (de) Verfahren zur herstellung einer polymermodifizierten elektrode.
ATA354585A (de) Verfahren zur herstellung von krebszellen bekaempfenden lymphocyten
AT378186B (de) Verfahren zur herstellung von cimetidin
DE3677405D1 (de) Verfahren zur herstellung von naphthazarinderivaten.
AT369383B (de) Verfahren zur herstellung von beta-amidoethyl -ether-derivaten
ATA535281A (de) Verfahren zur herstellung von phenoxyisobutters|ureestern
ATA328581A (de) Verfahren zur herstellung von 1-phenoxy-3-amino- 2-propanolen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee